ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

Journal of Clinical Investigation

Volumn 108, Issue 2, 2001, Pages 303-309

  Vaisman, Boris L ^a   Lambert, Gilles ^a   Amar, Marcelo ^a   Joyce, Charles ^a   Ito, Toshimitsu ^a   Shamburek, Robert D ^a   Cain, William J ^b   Fruchart Najib, Jamila ^c   Neufeld, Edward D ^a   Remaley, Alan T ^a   Brewer Jr , H Bryan ^a   Santamarina Fojo, Silvia ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER; GENE PRODUCT; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; BILIARY EXCRETION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HYPERLIPOPROTEINEMIA; LIPID TRANSPORT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RISK FACTOR; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; HYPERLIPOPROTEINEMIAS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; LIVER; MACROPHAGES; MICE; MICE, TRANSGENIC;

EID: 0034958770     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200112517     Document Type: Article

References (47)

1. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
2. Intracellular cholesterol transport
3. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
4. Evolution of ATP-binding cassette transporter genes
5. Complete inventory of the yeast ABC proteins
6. Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred
7. Complete genomic sequence of the human ABCA1 gene: Analysis of the human and mouse ATP-binding cassette A promoter
8. Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds
9. Analysis of hABC1 gene 5′ end: Additional peptide sequence, promoter region, and four polymorphisms
10. Molecular cloning of the human ATP-binding cassette transport 1 (hABC1): Evidence of sterol-dependent regulation in macrophages
11. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
12. Scavenger receptor-B1 inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages
13. Identification of cAMP analogue inducible genes in RAW264 macrophages
14. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP
15. Tangier disease is caused by mutations in the ATP binding cassette transporter 1 (ABC1) gene
16. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
17. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
18. Common and rare ABCA1 variants affecting plasma HDL cholesterol
19. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: Role of the ABCA1 gene mutations
20. ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
21. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux
22. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
23. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency
24. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice
25. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins
26. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice
27. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis
28. Two-dimensional eletrophoresis of plasma lipoproteins: Recognition of new apo A-I containing subpopulations
29. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin cholesteryl acyltransferase
30. Methods for assessment of tissue sites of lipoprotein degradation
31. Efficient trace-labeling of proteins with iodine
32. Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters
33. ApoA-I knockout mice: Characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes
34. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
35. The pathogenesis of atherosclerosis: A perspective for the 1990s
36. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol
37. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism
38. Regulation and activity of the human ABCA1 gene in transgenic mice
39. Expression of murine LCAT in transgenic mice: Evaluation of the role of LCAT cholesteryl ester-fatty acid specificity in the development of atherosclerosis
40. Metabolism of high density lipoprotein sub-fractions and constituents in Tangier disease following the infusion of high density lipoproteins
41. Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia
42. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size: Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution
43. The influence of lipid on the conformation of human plasma high density apolipoproteins
44. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: Differences between males and females
45. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
46. Biliary cholesterol excretion: A novel mechanism that regulates dietary cholesterol absorption
47. Adenovirus-mediated expression establishes an in vivo role for human ABCG1 (ABC8) in lipoprotein metabolism